Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Emerg Infect Dis ; 25(9): 1753-1756, 2019 09.
Artigo em Inglês | MEDLINE | ID: mdl-31441759

RESUMO

Lassa fever has not been reported in Côte d'Ivoire. We performed a retrospective analysis of human serum samples collected in Côte d'Ivoire in the dry seasons (January-April) during 2015-2018. We identified a fatal human case of Lassa fever in the Bangolo District of western Côte d'Ivoire during 2015.


Assuntos
Febre Lassa/epidemiologia , Vírus Lassa/isolamento & purificação , Adulto , Animais , Côte d'Ivoire/epidemiologia , Reservatórios de Doenças , Feminino , Humanos , Febre Lassa/sangue , Febre Lassa/transmissão , Febre Lassa/virologia , Vírus Lassa/genética , Masculino , Estudos Retrospectivos , Roedores , Estudos Soroepidemiológicos
2.
Malar J ; 17(1): 413, 2018 Nov 07.
Artigo em Inglês | MEDLINE | ID: mdl-30404640

RESUMO

BACKGROUND: Resistance of Plasmodium falciparum to anti-malarial drugs has hampered efforts to eradicate malaria. Recent reports of a decline in the prevalence of chloroquine-resistant P. falciparum in several countries, including Malawi and Zambia, is raising the hope of reintroducing chloroquine in the near future, ideally in combination with another anti-malarial drug for the treatment of uncomplicated malaria. In Côte d'Ivoire, the decrease in the clinical efficacy of chloroquine, in addition to a high proportion of clinical isolates carrying the Thr-76 mutant allele of the pfcrt gene, had led to the discontinuation of the use of chloroquine in 2004. Previous studies have indicated the persistence of a high prevalence of the Thr-76 mutant allele despite the withdrawal of chloroquine as first-line anti-malarial drug. This present study is conducted to determine the prevalence of the Thr-76T mutant allele of the Pfcrt gene after a decade of the ban on the sale and use of chloroquine in Côte d'Ivoire. RESULTS: Analysis of the 64 sequences from all three study sites indicated a prevalence of 15% (10/64) of the Thr-76 mutant allele against 62% (40/64) of the Lys-76 wild-type allele. No mutation of the allele Thr-76 was observed at Anonkoua Kouté while this mutant allele was in 31% (5/16) and 25% (5/20) of isolate sequences from Port-Bouët and Ayamé respectively. CONCLUSION: More than a decade after the discontinuation of the use of chloroquine in Côte d'Ivoire, the proportion of parasites sensitive to this anti-malarial seems to increase in Anonkoua-kouté, Port-bouët and Ayamé.


Assuntos
Antimaláricos/farmacologia , Cloroquina/farmacologia , Resistência a Medicamentos/genética , Proteínas de Membrana Transportadoras/genética , Plasmodium falciparum/genética , Proteínas de Protozoários/genética , Côte d'Ivoire , Malária Falciparum/prevenção & controle , Plasmodium falciparum/efeitos dos fármacos
3.
PLoS Negl Trop Dis ; 12(7): e0006572, 2018 07.
Artigo em Inglês | MEDLINE | ID: mdl-29965961

RESUMO

BACKGROUND: The environmental pathogen, Mycobacterium ulcerans (MU) can infect both humans and animals and cause Buruli ulcer (BU) disease. However, its mode(s) of transmission from the colonized environment to human/animal hosts remain unclear. In Australia, MU can infect both wildlife and domestic mammals. Till date, BU-like lesions have only been reported in wildlife in Africa. This warrants a thorough assessment of possible MU in domestic animals in Africa. Here, we screened roaming domesticated animals that share the human microhabitat in two different BU endemic sites, Sedje-Denou in Benin and Akonolinga in Cameroon, for MU lesions. METHODOLOGY/PRINCIPAL FINDINGS: We screened roaming mammals and birds across 3 endemic villages of Sedje-Denou in Southern Benin and 6 endemic villages of Akonolinga in Cameroon. After approval from relevant authorities, specimens (wound swabs and tissue fragments) were collected from animals with open or active lesion and systematically screened to detect the presence of MU though the diagnostic DNA targets IS2404, IS2606 and KR-B. Out of 397 animals surveyed in Akonolinga, 44 (11.08%) carried skin lesions and all were negative for MU DNA. For Sedje-Denou, only 25 (6.93%) out of 361 animals surveyed carried external skin lesions of which 2 (8%) were positive for MU DNA targets. These MU infected lesions were found in two different villages on a goat (abdominal part) and on a dog (nape area of the neck). Source-tracking of MU isolates within infected animal lesions was performed using VNTR genotyping and further confirmed with sequencing. One MU VNTR genotype (Z) was successfully typed from the goat lesion. The evolutionary history inferred from sequenced data revealed a clustering of animal MU isolates within isolates from human lesions. CONCLUSION/SIGNIFICANCE: This study describes the first report of two MU infected lesions in domestic animals in Africa. Their DNA sequence analyses show close relationship to isolates from human cases. It suggests that MU infection should be suspected in domestic hosts and these could play a role in transmission. The findings further support the hypothesis that MU is a ubiquitous environmental pathogen found in endemic areas, and probably involved in a multiple transmission pathway.


Assuntos
Animais Domésticos/microbiologia , Úlcera de Buruli/transmissão , Úlcera de Buruli/veterinária , Mycobacterium ulcerans/isolamento & purificação , Zoonoses/transmissão , Animais , Benin , Úlcera de Buruli/microbiologia , Camarões , Galinhas , Doenças do Cão/microbiologia , Cães , Patos , Feminino , Genótipo , Doenças das Cabras/microbiologia , Cabras , Humanos , Masculino , Mycobacterium ulcerans/classificação , Mycobacterium ulcerans/genética , Mycobacterium ulcerans/fisiologia , Filogenia , Doenças das Aves Domésticas/microbiologia , Ovinos , Doenças dos Ovinos/microbiologia , Zoonoses/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...